GlassScriptPhysician profile
Jeremy S Albin
NPI 1336376284
$15,734.82
in general payments reported to CMS, 2019-2025
21 companies · $4,151 in 2025
The $4,151 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,914 · 2020: $154 · 2021: $8,260 · 2022: $952 · 2023: $147 · 2024: $157 · 2025: $4,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Education: $750 · Travel and Lodging: $748 · Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Education | $750.00 |
| Travel and Lodging | $747.68 |
| Food and Beverage | $457.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,274.61 | 2021-2025 | |
| Virtual Incision Corporation | $2,500.00 | 2025 | Mira |
| Medtronic Vascular, INC. | $1,658.26 | 2019 | |
| Organogenesis INC. | $251.93 | 2019-2025 | Puraply, Novachor |
| Smith+Nephew, INC. | $175.86 | 2019-2024 | Grafix Pl |
| Heron Therapeutics, INC. | $162.44 | 2021-2022 | |
| Kerecis Limited | $131.43 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Musculoskeletal Transplant Foundation INC. | $92.92 | 2020-2021 | |
| Medtronic, INC. | $83.80 | 2022 | |
| Davol INC. | $55.86 | 2019-2021 | |
| Melinta Therapeutics, LLC | $52.93 | 2019-2022 | |
| Polynovo North America LLC | $46.23 | 2023-2025 | Novosorb Btm |
| Boston Scientific Corporation | $44.16 | 2024 | Varithena Administration Pack, Resolution 360 Ultra Clip |
| Integra Lifesciences Corporation | $36.71 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Lifenet Health | $33.63 | 2024 | Theragenesis Wound Matrix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $30.63 | 2021-2022 | |
| Portola Pharmaceuticals, LLC | $28.91 | 2019 | |
| Kci USA, INC. | $23.83 | 2023 | Activ.A.C., Prevena, V.A.C. Dermatac |
| Mimedx Group, INC. | $21.87 | 2024 | |
| Braintree Laboratories, INC. | $14.98 | 2024 | Suflave, Sutab |
| Medline Industries LP | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Albin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.